Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Nucleic Acid Amplification Testing Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The nucleic acid amplification testing market has seen significant expansion in recent times. Its value is expected to rise from $11.03 billion in 2025 to $12.7 billion in 2026, registering a compound annual growth rate (CAGR) of 15.2%. The historical increase in this market can be attributed to several factors including infectious disease outbreaks, the proliferation of clinical laboratories, the widespread adoption of PCR technology, various public health screening initiatives, and a decrease in assay expenses.
The nucleic acid amplification testing market is projected to experience swift expansion in the coming years. It will grow to $22.1 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. This anticipated growth can be attributed to several factors such as the advancements in personalized medicine, the escalating demand for rapid diagnostic solutions, the expansion into emerging markets, ongoing technological miniaturization, and the regulatory approvals granted for novel assays. Furthermore, major developments expected during this period include the proliferation of rapid point-of-care molecular testing, the broadened application of multiplex and syndromic panels, an increase in the adoption of isothermal amplification techniques, the rise of home-based and decentralized testing options, and a heightened focus on early disease detection.
Get A Free Sample Report With In-Depth Market Insights:
Nucleic Acid Amplification Testing Market Growth Drivers: What’s Behind The Acceleration?
The escalating occurrence of infectious diseases is anticipated to propel the expansion of the nucleic acid amplification testing market moving forward. These diseases are conditions originating from organisms that can transmit between individuals, either directly or indirectly, through various avenues such as physical contact, airborne particles, tainted food or water, or vector-borne spread by insects. The surge in infectious diseases is attributed to factors like antibiotic resistance, climate change, alterations in human behavior, and agricultural practices. Nucleic acid amplification testing (NAAT) plays a crucial role by swiftly and precisely identifying infectious pathogens, thus enabling prompt diagnosis and treatment, which effectively assists in curbing disease dissemination. For instance, in October 2023, the Public Health Agency of Canada, a Canada-based government agency, disclosed that during the 2022–2023 season, 4,216 hospitalizations related to influenza were reported by participating provinces and territories. Hence, the increasing incidence of infectious diseases significantly drives the growth of the nucleic acid amplification testing market.
Nucleic Acid Amplification Testing Market Segmentation: How Does The Market Break Down By Category?
The nucleic acid amplification testing market covered in this report is segmented –
1) By Type: Target Amplification Systems, Probe Amplification Systems, Signal Amplification Systems
2) By Amplification Method: Consumables, Instruments Or Systems
3) By Technology: Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, Ligase Chain Reaction (LCR) Tests
4) By Application: Infectious Disease Testing, Oncology Testing, Genetic And Mitochondrial Disease Testing, Other Applications
5) By End-Use: Hospitals, Diagnostic Laboratories, Biotechnology Companies, Other End-Users
Subsegments:
1) By Target Amplification Systems: Polymerase Chain Reaction (PCR), Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Nested PCR, Multiplex PCR, LAMP (Loop-Mediated Isothermal Amplification),
2) By Probe Amplification Systems: Nucleic Acid Sequence-Based Amplification (NASBA), Hybridization-Based Amplification, Branch Chain Amplification (BCA), Strand Displacement Amplification (SDA),
3) By Signal Amplification Systems: Enzyme-Linked Signal Amplification, Fluorescent Signal Amplification, Chemiluminescent Signal Amplification, Electrochemical Signal Amplification, Magnetic Particle-Based Signal Amplification
Nucleic Acid Amplification Testing Market Trends: What’s Defining The Industry’s Next Phase?
Companies operating in the nucleic acid amplification testing market are prioritizing the development of innovative solutions, such as in vitro diagnostics (IVD) assays, to screen donated blood for CMV using nucleic acid amplification technology (NAT) in accordance with the IVDR. An IVD (in vitro diagnostic) assay refers to a test conducted on biological samples to detect diseases, conditions, or infections outside the body within a laboratory setting. For instance, in June 2024, GFE, a Germany-based company, launched the PoET CMV. This PoET CMV, an IVD assay, is specifically designed for the swift and accurate detection of cytomegalovirus (CMV) infections. Its notable features include high sensitivity and specificity, enabling early diagnosis and effective management of CMV in transplant recipients and individuals with weakened immune systems. The assay leverages advanced molecular techniques to deliver reliable results quickly, thereby supporting timely clinical decision-making.
Nucleic Acid Amplification Testing Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the nucleic acid amplification testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., Cepheid Inc., GenScript Biotech Corporation, ARUP Laboratories, BGI Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Eiken Chemical Co. Ltd., New England Biolabs Inc., TwistDx Limited, Bioneer Corporation
View The Full Nucleic Acid Amplification Testing Market Report:
Nucleic Acid Amplification Testing Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the nucleic acid amplification testing (NAAT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid amplification testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
